These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 1764869)

  • 1. Clinical pharmacokinetics of famotidine.
    Echizen H; Ishizaki T
    Clin Pharmacokinet; 1991 Sep; 21(3):178-94. PubMed ID: 1764869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic and pharmacodynamic properties of histamine H2-receptor antagonists. Relationship between intrinsic potency and effective plasma concentrations.
    Lin JH
    Clin Pharmacokinet; 1991 Mar; 20(3):218-36. PubMed ID: 1673880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
    Hatlebakk JG; Berstad A
    Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and dynamics of famotidine in patients with renal failure.
    Gladziwa U; Klotz U; Krishna DR; Schmitt H; Glöckner WM; Mann H
    Br J Clin Pharmacol; 1988 Sep; 26(3):315-21. PubMed ID: 2902874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of famotidine in paediatric patients.
    James LP; Kearns GL
    Clin Pharmacokinet; 1996 Aug; 31(2):103-10. PubMed ID: 8853932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of famotidine in elderly patients with and without renal insufficiency and in healthy young volunteers.
    Inotsume N; Nishimura M; Fujiyama S; Sagara K; Sato T; Imai Y; Matsui H; Nakano M
    Eur J Clin Pharmacol; 1989; 36(5):517-20. PubMed ID: 2568929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Famotidine and theophylline pharmacokinetics. An unexpected cimetidine-like interaction in patients with chronic obstructive pulmonary disease.
    Dal Negro R; Pomari C; Turco P
    Clin Pharmacokinet; 1993 Mar; 24(3):255-8. PubMed ID: 8462230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of age and chronic renal failure on the urinary excretion kinetics of famotidine in man.
    Lin JH; Chremos AN; Yeh KC; Antonello J; Hessey GA
    Eur J Clin Pharmacol; 1988; 34(1):41-6. PubMed ID: 2896129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary excretion kinetics of famotidine in rats.
    Lin JH; Los LE; Ulm EH; Duggan DE
    Drug Metab Dispos; 1987; 15(2):212-6. PubMed ID: 2882981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does H2 receptor antagonist-resistant ulcer exist?--A review based on bioavailability in man.
    Kawai K
    Gastroenterol Jpn; 1992 Jun; 27(3):418-23. PubMed ID: 1624085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamics of famotidine in humans.
    Chremos AN
    Am J Med; 1986 Oct; 81(4B):3-7. PubMed ID: 2877572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacokinetics of ranitidine.
    Roberts CJ
    Clin Pharmacokinet; 1984; 9(3):211-21. PubMed ID: 6329583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacology of famotidine: a summary.
    Chremos AN
    J Clin Gastroenterol; 1987; 9 Suppl 2():7-12. PubMed ID: 2887616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newer H2-receptor antagonists. Clinical pharmacokinetics and drug interaction potential.
    Krishna DR; Klotz U
    Clin Pharmacokinet; 1988 Oct; 15(4):205-15. PubMed ID: 2903807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of famotidine after intravenous administration in liver disease.
    Ohnishi K
    Am J Gastroenterol; 1991 Jan; 86(1):41-5. PubMed ID: 1986553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Famotidine pharmacokinetics following oral and intravenous administration in patients with liver disease: results of a preliminary study.
    Morgan MY; Stambuk D
    Postgrad Med J; 1986; 62 Suppl 2():29-37. PubMed ID: 2890149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of famotidine on renal function in patients with renal insufficiency.
    Abraham PA; Opsahl JA; Halstenson CE; Chremos AN; Matzke GR; Keane WF
    Br J Clin Pharmacol; 1987 Sep; 24(3):385-9. PubMed ID: 2889461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of H2 receptor blockers on renal function. An attempt to accurately measure glomerular filtration].
    Motyl W
    Ann Acad Med Stetin; 2004; 50(1):97-105. PubMed ID: 16871748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of the speed of acid-suppressing effects of oral administration of cimetidine and famotidine.
    Adachi K; Komazawa Y; Mihara T; Azumi T; Fujisawa T; Katsube T; Furuta K; Kinoshita Y
    J Gastroenterol Hepatol; 2005 Jul; 20(7):1012-5. PubMed ID: 15955208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inhibitory effect of probenecid on renal excretion of famotidine in young, healthy volunteers.
    Inotsume N; Nishimura M; Nakano M; Fujiyama S; Sato T
    J Clin Pharmacol; 1990 Jan; 30(1):50-6. PubMed ID: 2303581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.